Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial nitroreductases are a diverse family of flavin mononucleotide (FMN)-dependent oxidoreductase enzymes predominantly found in bacteria. These enzymes catalyze the reduction of nitro groups on aromatic and heterocyclic compounds, converting them into amino or hydroxylamino derivatives. They are used in prodrug activation for cancer therapy, cell ablation models, bioremediation, and imaging applications. Engineered variants exist with enhanced catalytic efficiency and altered substrate specificity.
Reduction of nitro groups on aromatic and heterocyclic compounds
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Nitroreductase Enzyme (NTR).